|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 758.91 USD | -1.18% |
|
-2.27% | -1.68% |
| 14/01 | Regeneron's Yancopoulos on Hearing Loss Gene Therapy, Weight Loss Drugs | MT |
| 13/01 | Jefferies Adjusts Price Target on Regeneron Pharmaceuticals to $885 From $870, Maintains Buy Rating | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Biopharmaceuticals | -1.18% | -2.27% | -1.68% | +5.86% | +48.25% | 7.79TCr |  | | |
- Stock Market
- Equities
- REGN Stock
- Charts Regeneron Pharmaceuticals, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition